SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOxford Instruments Regulatory News (OXIG)

Share Price Information for Oxford Instruments (OXIG)

Share Price is delayed by 15 minutes
Get Live Data
2,878.00    130.00 (4.73%)
Bid:
2,846.00
Ask:
2,862.00
Spread: 16.00 (0.562%)
Market Cap: £1.59b
OXIG Live PriceLast checked at - London Stock Exchange

Intraday Oxford Instruments Share Chart

AGM Statement

11 Sep 2012 07:00

RNS Number : 9360L
Oxford Instruments PLC
11 September 2012
 



Release time & date: 7:00am 11/09/2012

 

Oxford Instruments plc Chairman's AGM Statement 2012

 

 

Oxford Instruments plc, a leading provider of high technology tools and systems for industry and research, is holding its annual general meeting today in which the Chairman, Nigel Keen will make the following statement:

 

"In June 2011 we outlined our 14 cubed objective to achieve a compound annual revenue growth rate of 14% and a return on sales of 14% by the financial year ending March 2014. It is anticipated that this objective will be achieved predominantly through organic growth and continuing internal efficiency improvements, augmented by targeted bolt on acquisitions.

 

The year to March 2012 was the first year of the 14 Cubed plan and we reported sales growth of 29% split equally between organic growth and the three bolt-on acquisitions we made to strengthen our competitive position. Return on sales also improved in line with our targets, increasing from 10.7% to 12.5%

 

In the current year our Nanotechnology Tools business has made good progress as Oxford Instruments' customers use our equipment to work at the frontiers of science and improve the efficiency of high technology production facilities. The launch of our new XMax large area detector in August has further consolidated our position as a leading provider of advanced material analysis equipment.

 

Over the same period our Industrial division has also continued to trade in line with expectations. Our customers use Oxford Instruments' equipment to implement high-tech manufacturing strategies for advanced materials and products. Sales have been helped by the launch of the new X-MET 7500 hand held material analyser which is helping to grow our market share.

 

The Service division has performed well providing aftermarket service to the installed base of Oxford Instruments equipment. The Platinum Medical Imaging business acquired in November last year has integrated well and further strengthened our offering in this area.

 

Order intake from our research markets remains good although as expected there has been some softness in our industrial markets. Despite the ongoing uncertainties in global economies, we believe the diversity of our activities combined with our strong pipe-line of new products will continue to provide good growth opportunities for the Group.

 

The Board anticipates that Oxford Instruments will continue to make progress in line with our expectations for the financial year."

 

  

- Ends -

Issued for and on behalf of Oxford Instruments plc

 

 

For further information please contact:

 

Oxford Instruments Plc

+44 (0)1865 393200

Jonathan Flint - Chief Executive

Kevin Boyd - Group Finance Director

MHP Communications

+44 (0)20 3128 8100

Rachel Hirst / Ian Payne

 

Notes to Editors  

 

About Oxford Instruments plc

Oxford Instruments designs, supplies and supports high-technology tools and systems with a focus on research and industrial applications. It provides solutions needed to advance fundamental physics research and its transfer into commercial nanotechnology applications. Innovation has been the driving force behind Oxford Instruments' growth and success for over 50 years, and its strategy is to effect the successful commercialisation of these ideas by bringing them to market in a timely and customer-focused fashion. 

The first technology business to be spun out from Oxford University over fifty years ago, Oxford Instruments is now a global company with over 1900 staff worldwide and is listed on the FTSE250 index of the London Stock Exchange (OXIG).  Its objective is to be the leading provider of new generation tools and systems for the research and industrial sectors.

This involves the combination of core technologies in areas such as low temperature, high magnetic field and ultra high vacuum environments, Nuclear Magnetic Resonance, X-ray, electron and optical based metrology, and advanced growth, deposition and etching.

Oxford Instruments aims to pursue responsible development and deeper understanding of our world through science and technology. Its products, expertise, and ideas address global issues such as energy, environment, security and health.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGMURUNRUOAKAAR
Date   Source Headline
25th Jul 20257:00 amPRNDirector/PDMR Shareholding
25th Jul 20257:00 amPRNTransaction in Own Shares
24th Jul 20257:00 amPRNTransaction in Own Shares
23rd Jul 20257:00 amPRNTransaction in Own Shares
22nd Jul 20257:00 amPRNTransaction in Own Shares
21st Jul 20257:00 amPRNTransaction in Own Shares
18th Jul 20257:00 amPRNTransaction in Own Shares
17th Jul 20257:00 amPRNTransaction in Own Shares
16th Jul 20257:00 amPRNTransaction in Own Shares
15th Jul 20257:00 amPRNTransaction in Own Shares
14th Jul 20257:00 amPRNTransaction in Own Shares
11th Jul 20251:35 pmPRNDirector/PDMR Shareholding
11th Jul 20257:00 amPRNTransaction in Own Shares
10th Jul 20257:00 amPRNTransaction in Own Shares
9th Jul 20257:00 amPRNTransaction in Own Shares
8th Jul 20257:00 amPRNTransaction in Own Shares
7th Jul 202510:30 amPRNHolding(s) in Company
7th Jul 20257:00 amPRNTransaction in Own Shares
4th Jul 20257:00 amPRNTransaction in Own Shares
3rd Jul 20257:00 amPRNTransaction in Own Shares
2nd Jul 20254:07 pmPRNDirector/PDMR Shareholding - purchase of shares
2nd Jul 20257:00 amPRNTransaction in Own Shares
1st Jul 202512:28 pmPRNBlocklisting - Interim Review
1st Jul 202512:28 pmPRNTotal Voting Rights
1st Jul 20257:00 amPRNTransaction in Own Shares
30th Jun 20257:00 amPRNTransaction in Own Shares
27th Jun 20257:00 amPRNTransaction in Own Shares
26th Jun 20252:02 pmPRNBlock Listing Application
26th Jun 20257:00 amPRNTransaction in Own Shares
25th Jun 202512:14 pmPRNPublication of Annual Report 2025 and Notice of Annual General Meeting 2025
25th Jun 20257:00 amPRNCommencement of Share Buyback
24th Jun 20259:30 amPRNHolding(s) in Company
20th Jun 20257:00 amPRNDirector/PDMR Shareholding
18th Jun 20254:30 pmPRNHolding(s) in Company
13th Jun 20257:00 amRNSPreliminary Results
12th Jun 20252:43 pmRNSAnnouncement of Preliminary Results
11th Jun 20252:38 pmPRNDirector/PDMR Shareholding
10th Jun 20254:12 pmPRNHolding(s) in Company
10th Jun 20257:00 amRNSDelay to announcement of preliminary results
10th Jun 20257:00 amRNSSale of Oxford Instruments’ quantum business
2nd Jun 202512:33 pmPRNTotal Voting Rights
13th May 20253:45 pmPRNDirector/PDMR Shareholding
22nd Apr 20253:40 pmPRNHolding(s) in Company
17th Apr 20251:40 pmPRNHolding(s) in Company
16th Apr 20257:00 amRNSTrading Update
15th Apr 20251:30 pmPRNHolding(s) in Company
14th Apr 20253:33 pmPRNDirector/PDMR Shareholding
10th Apr 20257:00 amRNSHolding(s) in Company
1st Apr 20257:00 amRNSTotal Voting Rights
25th Mar 202512:35 pmPRNHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.